ECSP10010499A - PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTALLINE FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE - Google Patents
PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTALLINE FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDEInfo
- Publication number
- ECSP10010499A ECSP10010499A EC2010010499A ECSP10010499A ECSP10010499A EC SP10010499 A ECSP10010499 A EC SP10010499A EC 2010010499 A EC2010010499 A EC 2010010499A EC SP10010499 A ECSP10010499 A EC SP10010499A EC SP10010499 A ECSP10010499 A EC SP10010499A
- Authority
- EC
- Ecuador
- Prior art keywords
- preparation
- sulfamates
- benzofused
- heteroarilo
- benzodioxin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
La presente invención se dirige a un proceso para la preparación de sulfamatos de heteroarilo benzofusionado, útiles para el tratamiento de epilepsia y trastornos relacionados, de conformidad con la Fórmula (IA) y con un compuesto cristalino de la Fórmula (I-S).Proceso para la preparación de un compuesto de Fórmula (IA).The present invention is directed to a process for the preparation of benzofused heteroaryl sulfamates, useful for the treatment of epilepsy and related disorders, in accordance with Formula (IA) and with a crystalline compound of Formula (IS). Preparation of a compound of Formula (IA).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/058233 WO2009120191A1 (en) | 2008-03-26 | 2008-03-26 | Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010499A true ECSP10010499A (en) | 2010-10-30 |
Family
ID=40030223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010499A ECSP10010499A (en) | 2008-03-26 | 2010-09-24 | PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTALLINE FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2280950A1 (en) |
JP (1) | JP2011515464A (en) |
KR (1) | KR20100126535A (en) |
CN (1) | CN101981019A (en) |
AU (1) | AU2008353491A1 (en) |
BR (1) | BRPI0822454A2 (en) |
CA (1) | CA2719624A1 (en) |
CR (1) | CR11761A (en) |
EA (1) | EA201071120A1 (en) |
EC (1) | ECSP10010499A (en) |
IL (1) | IL208222A0 (en) |
MX (1) | MX2010010595A (en) |
WO (1) | WO2009120191A1 (en) |
ZA (1) | ZA201007611B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
JP2008545650A (en) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Method for producing sulfamide derivative |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
MX2011000090A (en) * | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems. |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
CN107954906B (en) * | 2017-11-24 | 2020-10-16 | 西北师范大学 | Synthetic method of aryl sulfonyl tertiary amine compound |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
MX2007002309A (en) * | 2004-08-24 | 2007-10-08 | Johnson & Johnson | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents. |
TW200738669A (en) * | 2006-02-22 | 2007-10-16 | Janssen Pharmaceutica Nv | Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide |
-
2008
- 2008-03-26 EP EP08744381A patent/EP2280950A1/en not_active Withdrawn
- 2008-03-26 MX MX2010010595A patent/MX2010010595A/en unknown
- 2008-03-26 JP JP2011501761A patent/JP2011515464A/en not_active Withdrawn
- 2008-03-26 EA EA201071120A patent/EA201071120A1/en unknown
- 2008-03-26 CA CA2719624A patent/CA2719624A1/en not_active Abandoned
- 2008-03-26 KR KR1020107023447A patent/KR20100126535A/en not_active Application Discontinuation
- 2008-03-26 CN CN2008801285434A patent/CN101981019A/en active Pending
- 2008-03-26 AU AU2008353491A patent/AU2008353491A1/en not_active Abandoned
- 2008-03-26 WO PCT/US2008/058233 patent/WO2009120191A1/en active Application Filing
- 2008-03-26 BR BRPI0822454-4A patent/BRPI0822454A2/en not_active IP Right Cessation
-
2010
- 2010-09-19 IL IL208222A patent/IL208222A0/en unknown
- 2010-09-24 EC EC2010010499A patent/ECSP10010499A/en unknown
- 2010-10-25 ZA ZA2010/07611A patent/ZA201007611B/en unknown
- 2010-10-26 CR CR11761A patent/CR11761A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101981019A (en) | 2011-02-23 |
KR20100126535A (en) | 2010-12-01 |
AU2008353491A1 (en) | 2009-10-01 |
EA201071120A1 (en) | 2011-06-30 |
WO2009120191A1 (en) | 2009-10-01 |
IL208222A0 (en) | 2010-12-30 |
CR11761A (en) | 2011-07-06 |
CA2719624A1 (en) | 2009-10-01 |
BRPI0822454A2 (en) | 2015-06-16 |
ZA201007611B (en) | 2012-04-25 |
MX2010010595A (en) | 2010-10-25 |
JP2011515464A (en) | 2011-05-19 |
EP2280950A1 (en) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010499A (en) | PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTALLINE FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4-BENZODIOXIN-2IL) METHYL-SULFAMIDE | |
ECSP10010498A (en) | PROCESSES FOR THE PREPARATION OF BENZOFUSED HETEROARILO DERIVATIVES | |
BRPI1013426A2 (en) | organisms for the production of 1,3-butanediol | |
JP2013540893A5 (en) | ||
BRPI0905147A8 (en) | process for synthesizing ivabradine and its addition salts with a pharmaceutically acceptable acid | |
AR061311A1 (en) | PROCESSES TO PREPARE CINACALCET CHLORHYDRATE AND POLYMORPHIC FORMS OF THE SAME | |
UY31803A (en) | CRYSTAL COMPOUND | |
CR20160465A (en) | POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275) | |
AR058253A1 (en) | PROCEDURE FOR THE PREPARATION OF FERRI-SUCCINILCASEINA | |
CL2013001221A1 (en) | Compound (4a-r, 9a-s) -1- (1h-benzoimidazol-5-carbonyl-2,3,4,4a, 9,9a-hexahydro-1h-inden [2,1-b] pyridine hydrochloride -6-carbonitrile and its crystalline forms i and ii, hsd 1 inhibitors; pharmaceutical composition; method for producing the crystalline form i of the compound; method for producing crystalline form ii of the compound. | |
CU23820A3 (en) | (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND OBTAINING PROCEDURE | |
CL2011001405A1 (en) | Procedure for the preparation of n- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, agomethalin. | |
CL2008002532A1 (en) | Synthesis process of a pyrido- [2,1-a] isoquinoline derivative; crystalline forms of said compounds; and its use to treat diabetes, diabetes mellitus, glucose intolerance disorder. | |
BR112012009611A2 (en) | '' process for the preparation of a compound of formula (i) '' | |
EA201170481A1 (en) | SKIN CRYSTALS | |
BRPI0914400A2 (en) | "process for the synthesis of a compound" | |
EP2770089A4 (en) | Method for producing nitride semiconductor crystal of group 13 metal of periodic table, and nitride semiconductor crystal of group 13 metal of periodic table produced by said production method | |
BRPI1007718A2 (en) | process for the production of sodium cyanide crystals | |
GT200900215A (en) | NEW PROCEDURE FOR OBTAINING THE CRYSTALLINE V FORM OF AGOMELATINE. | |
CL2012000270A1 (en) | Preparation procedure of ivabradine and its addition salts by formation of the benzoacepine ring; and the intermediary compounds considered in the process. | |
BRPI1006374A2 (en) | "Process for the preparation of etoricoxib, compound, process for the purification of etoricoxib, polymorphic form, etoricoxib" | |
CO6390054A2 (en) | CRYSTAL FORMS OF A 3-CARBOXIPROPIL-AMINOTETRALINE COMPOUND | |
CO6290652A2 (en) | PROCESS FOR THE PREPARATION OF BENZOFUSED HETEROARILO SULFAMATES AND THE CRYSTAL FORM OF N - (((2S) -6-CHLORINE-2,3-DIHYDRO-1,4BENZODIOXIN-2IL) METHYL-SULFAMIDE | |
AR064215A1 (en) | PROCESS FOR OBTAINING R-ENANTIOMERO DE SALBUTAMOL | |
BRPI0914350A2 (en) | "process for the synthesis of a compound" |